These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5678843)

  • 1. [Controlled blood pressure reduction in chronic renal insufficiency].
    Buder HW; Precht K
    Dtsch Gesundheitsw; 1968 May; 23(19):879-81. PubMed ID: 5678843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Features of hypotensive therapy in patients with chronic renal insufficiency].
    Glezer GA; Ratner NA; Charyev M
    Klin Med (Mosk); 1971 Oct; 49(10):110-6. PubMed ID: 5133132
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure.
    Branca GF; Satta A; Faedda R; Soggia G; Olmeo NA; Vacca R; Bartoli E
    Panminerva Med; 1983; 25(4):215-8. PubMed ID: 6672713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of hypertension in chronic kidney insufficiency].
    Vorburger C
    Schweiz Med Wochenschr; 1974 Jul; 104(27):946-50. PubMed ID: 4460232
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of antihypertensives in advanced renal insufficiency].
    Gasparović V
    Lijec Vjesn; 1985 May; 107(5):217-8. PubMed ID: 4010455
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic modalities of hypertension in patients in a state of chronic kidney insufficiency].
    Fillastre JP; Leroy J; Dubois D
    Coeur Med Interne; 1971; 10(2):247-51. PubMed ID: 5568267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.
    Lazarus JM; Hampers C; Merrill JP
    Arch Intern Med; 1974 Jun; 133(6):1059-66. PubMed ID: 4597951
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arterial hypertension caused by chronic renal insufficiency. Pathogenesis and treatment].
    Niculescu P
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(1):13-8. PubMed ID: 1144971
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe hypertension in chronic renal failure treated successfully with Minoxidil.
    Schacht RA; Goldstein D; Martin DG
    Proc Eur Dial Transplant Assoc; 1975; 11():229-36. PubMed ID: 1197258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and prognosis of renal hypertension].
    Oshima K; Takeda T; Fukuchi S; Abe K; Kajiwara N
    Jpn Circ J; 1974 Apr; 38():Suppl:93-7. PubMed ID: 4406378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Causes of arterial hypertension and tactics of its treatment in chronic renal insufficiency at the terminal stage].
    Mazo EB; Maĭdanov ET
    Sov Med; 1975 Jul; (7):22-6. PubMed ID: 1216044
    [No Abstract]   [Full Text] [Related]  

  • 15. Slowing down chronic renal failure progression with various antihypertensive agents.
    Jovanović DB; Djukanović L; Naumović R
    Clin Nephrol; 1998 Dec; 50(6):390-2. PubMed ID: 9877115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive therapy in limited renal function].
    Lübbecke F
    Fortschr Med; 1986 Nov; 104(42):793-6. PubMed ID: 3804151
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of arterial hypertension with minoxidil in renal insufficiency].
    Federico S; Dal Canton A; Cianciaruso B; Gallo R; Usberti M
    Minerva Med; 1980 Oct; 71(39):2837-43. PubMed ID: 7432694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of endralazine (BQ-22-708) in patients with renal impairment and hypertension.
    Kingswood JC; Harrison PR; Banks RA; Higgs E; Mackenzie JC
    Postgrad Med J; 1983; 59 Suppl 3():173-6. PubMed ID: 6647204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R; Schmidt P; Widhalm F
    Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.